Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

French Prospective Observational Study of Patients Receiving Dupilumab for Atopic Dermatitis.

NCT06169527 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT06169527
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06169527 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
French Prospective Observational Study of Patients Receiving Dupilumab for Atopic Dermatitis.
Lead sponsor
Sanofi
Phase
Observational
Overall status
Active, not recruiting
Start date
November 28, 2023
Completion date
May 10, 2028
Enrollment
303 (actual)
Sites
42

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis